Results 51 to 60 of about 5,263,232 (399)

Intrinsic subtypes and bladder cancer metastasis

Asian Journal of Urology, 2016
Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics.
David J. McConkey, Woonyoung Choi, Andrea Ochoa, Colin P.N. Dinney   +3 more
doaj   +1 more source

TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

Journal of Translational Medicine, 2023
Background Bladder cancer is one of the most common malignant tumors of the urinary system and is associated with a poor prognosis once invasion and distant metastases occur.
Qinrong Ping, Chunhui Wang, Xin Cheng, Yiming Zhong, Ruping Yan, Meng Yang, Yunqiang Shi, Xiangmeng Li, Xiao Li, Wenwen Huang, Liqiong Wang, Xiaofang Bi, Libing Hu, Yang Yang, Yingbao Wang, Rui Gong, Jun Tan, Rui Li, Hui Li, Jian Li, Wenju Wang, Ruhong Li   +21 more
doaj   +1 more source

Recent patterns of bladder cancer incidence and mortality: a global overview [PDF]

World Cancer Research Journal, 2020
OBJECTIVE: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing death worldwide. The present study was conducted to investigate recent patterns of bladder cancer incidence and mortality worldwide.
M. Mohammadian, A. Safari, K. Allah Bakeshei, F. Allah Bakeshei, A. Asti, A. Mohammadian-Hafshejani, H. Salehiniya, M. Emamiyan, H. Khakpour   +8 more
doaj   +1 more source

Is the bladder filling protocol for prostate cancer patients undergoing radiotherapy fit for purpose? (Abstract only) [PDF]

, 2020
Introduction: Conventional radiotherapy has been planned with a full bladder based on the rationale that it will move the small bowel out of the treatment field and result in greater sparing of the bladder itself[1].
Burns, Donna, Mitchell, Joanne, Rosbottom, Keeley   +2 more
core   +1 more source

Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer

Clinical Cancer Research, 2021
Purpose: Bladder cancer treatment remains a major clinical challenge due to therapy resistance and a high recurrence rate. Profiling intratumor heterogeneity can reveal the molecular mechanism of bladder cancer recurrence.
Huanjun J Wang, Y. Mei, C. Luo, Qun Huang, Zifeng Wang, Guanming Lu, L. Qin, Zhun Sun, Chaowen Huang, Zhi-Wen Yang, Junxing Chen, Weiguo Yin, C. Qian, Jianming Zeng, Lingwu Chen, Q. Leng, Yan Guo, Guangshuai Jia   +17 more
semanticscholar   +1 more source

Evaluation of MMP‑2, MMP‑9, TIMP‑1, TIMP‑2, NGAL and MMP‑9/NGAL complex in urine and sera from patients with bladder cancer [PDF]

, 2015
The identification of biomarkers in urine or serum samples from patients with bladder cancer is urgently required for the development of non-invasive methods for the diagnosis of bladder carcinoma and to facilitate follow-up surveillance, to combat the ...
Bruzzese, Dario, DI CARLO, Angelina, Ricci, Serena   +2 more
core   +1 more source

Genetic and Epigenetic Alterations in Bladder Cancer [PDF]

International Neurourology Journal, 2016
Bladder cancer is one of the most common cancers worldwide, with a high rate of recurrence and poor outcomes as a result of relapse. Bladder cancer patients require lifelong invasive monitoring and treatment, making bladder cancer one of the most ...
Hong-Tao Li, Christopher E. Duymich, Daniel J. Weisenberger, Gangning Liang   +3 more
doaj   +1 more source

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. [PDF]

, 2012
BackgroundWe previously developed a bladder cancer-specific ligand (PLZ4) that can specifically bind to both human and dog bladder cancer cells in vitro and in vivo. We have also developed a micelle nanocarrier drug-delivery system.
de Vere White, Ralph, Gao, Tingjuan, Lam, Kit S, Lara, Primo N, Li, Yuanpei, Lin, Tzu-Yin, Luo, Juntao, Pan, Chong-Xian, Zhang, Hongyong   +8 more
core   +2 more sources

Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study [PDF]

, 2014
Background: There is evidence that cancer survivors are at increased risk of second primary cancers. Changes in the prevalence of risk factors and diagnostic techniques may have affected more recent risks.<p></p> Methods: We examined the
A Chopra, A Mehnert, Aishah Coyte, C Dong, C Fabbri, C Thellenberg, CH Johnson, D Brewster, D Brewster, D Brewster, D Forman, D Groheux, D Howel, David S Morrison, DM Parkin, DM Parkin, DR Youlden, E Crocetti, E Kellen, EM Ibrahim, F Levi, GB Yang, I Soerjomataram, IARC/ENCR/IACR Working Group, International Agency for Research on Cancer, J Ferlay, J Jegu, J Maddams, JA Atienza, JW Hotchkiss, K Hemminki, K Hemminki, K Moser, L Liu, L Liu, L Mellemkjaer, LJ Rutten, MB Adamo, MH Schmid-Wendtner, Philip McLoone, RE Curtis, S Scholes, X Gao, Y Chen   +43 more
core   +3 more sources

Advances in diagnosis and treatment of bladder cancer

British medical journal
Bladder cancer remains a leading cause of cancer death worldwide and is associated with substantial impacts on patient quality of life, morbidity, mortality, and cost to the healthcare system.
A. López-Beltran, M. S. Cookson, B. Guercio, Liang Cheng   +3 more
semanticscholar   +1 more source